Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
NOVEL PHARMACEUTICAL FORMULATION COMPRISING DUAL NK-1/NK-3 RECEPTOR ANTAGONISTS.

No-Receipt date 2024-00757 - 22/02/2024
No-Filing date 20240400455 - 22/02/2024
No-Granting date 3114759 - 27/02/2024
No-EPO application date 19711866.4 - 13/03/2019
No-EPO granting date 3765024 - 22/11/2023
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 2/2024 - 12/03/2024
Expiration date 14/03/2039
Kind of title Validation of European Patent
Legal status VALID
Priorities US201862642622 P14/03/2018/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 31/5383
A61K 47/14
A61K 9/08
A61K 9/48
A61P 25/00
A61P 5/24
C07D 498/04

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1583982 KANDY THERAPEUTICS LIMITED 400 SOUTH OAK WAYREADING, BERKSHIRE RG2 6AD UNITED KINGDOM (GREAT BRITAIN)

Inventors
CodeFirstnameSurname
4120973 TROWER, MIKE
4120974 KERR, MARY
4120975 ELDER, DAVID
4120976 LAZARO, MONICA
4120977 BUSH, DEREK

Representatives
CodeFirstnameSurnameAddressTownZip
3614AIKATERINISIOTOU "KATERINA SIOTOU KAI SYNERGATES DIKIGORIKI ETAIREIA"PATISION (28IS OKTOVRIOU) 122ATHINA (ATTIKIS)11257

Contact
CodeFirstnameSurnameAddressTownZipCountry
4766AIKATERINISIOTOUPATISION (28IS OKTOVRIOU) 122ATHINA (ATTIKIS)11257 GREECE

Owners History

Title Instruments

Payments history 7 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015
 
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).